Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease

Recruiting now · Phase 1

Conditions studied: Alzheimer Disease

In brief

This is a research study to evaluate the safety of an investigational autologous cell product obtained from participant's own adipose tissue as a possible treatment for Alzheimer disease.

Key facts

Study ID
NCT05667649
Run by
Regeneration Biomedical, Inc.
People needed
18
Starts
2023-08-14
Expected to finish
2026-08-01
Last updated by the study team
2025-04-04

Who can join

Age: 45 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.